57.5 F
Laguna Hills
Monday, Mar 18, 2024
-Advertisement-

Allergan Files for Approval of Eyelash Drug

Allergan Inc., an Irvine drug maker, said Wednesday it plans to file for Food and Drug Administration approval of a drug to spur eyelash growth.

The drug, bimatoprost, is the active ingredient in Allergan’s Lumigan glaucoma drug.

Allergan said it completed a clinical trial that showed bimatoprost, which is part of a family of hormone-like substances called prostaglandins, grew eyelashes when applied directly to them.

Allergan said it anticipates the FDA will approve bimatoprost for eyelash growth next year. If regulators sign off on it, it will be available on a prescription-only basis.

The company estimates that global peak sales for bimatoprost for eyelash growth could exceed $500 million a year.

Bimatoprost for eyelashes could eventually follow in the path of Allergan’s flagship Botox, which the company turned into what the Wall Street Journal’s called “a cosmetic superstar” after discovering that it temporary reduces wrinkles.

Want more from the best local business newspaper in the country?

Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!

-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-